Evestia Clinical ( formerly known as EMAS Pharma) has merged with Atlantic Research Group (ARG), a US-based CRO, to create an ...

RZL-012 is an injectable treatment for focal fat reduction that is currently progressing toward Phase 3 trials.

Antares Vision Group, a leader in the digitalization and traceability of products and supply chains for companies and ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has launched the AAW Automated ...

The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.

Zhaoke Ophthalmology Limited has reached a memorandum of agreement (MOA) with Fareva, a French contract manufacturing ...

Kane will advance strategic priorities and advance Solrikitug, its lead asset, in Phase II trials and prepare for Phase III.

Boehringer Ingelheim and LEO Pharma have signed an exclusive global license and transfer agreement to commercialize and ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

Cellular Origins, the Cell and Gene Therapy Catapult, and Resolution Therapeutics have formed a consortium funded by Innovate ...

The antibody, ISB 2001, is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) ...

The Flamma Group, a Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) and late-stage ...